ERBB2 and breast carcinoma: It has been proposed that activation of the ERK pathway by receptor tyrosine kinases, such as human epidermal growth factor receptor 2 (HER2/neu) increases miRNA-21 expression and downregulates PDCD4 in breast cancer cells (27).